期刊
TRENDS IN ENDOCRINOLOGY AND METABOLISM
卷 34, 期 7, 页码 392-394出版社
CELL PRESS
DOI: 10.1016/j.tem.2023.05.003
关键词
-
Doxorubicin (Dox) is an effective chemotherapy drug, but its clinical use is limited due to cardiotoxicity and the risk of heart failure. Recent research by Ozcan et al. suggests that alternate-day fasting (ADF) can significantly worsen the cardiotoxicity of Dox.
Doxorubicin (Dox) is a highly potent chemotherapy drug. Despite its efficacy, Dox's clinical application is limited due to its association with significant complications, namely cardiotoxicity and the risk of heart failure. Recent intriguing findings by Ozcan et al. indicate that alternate-day fasting (ADF) significantly exacerbates the cardiotoxicity of Dox.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据